Breathlessness predicts survival in patients with malignant pleural effusions: Meta-analysis of individual patient data from five randomized controlled trials

Mishra, Eleanor K., Muruganandan, Sanjeevan, Clark, Allan, Bhatnagar, Rahul, Maskell, Nick, Lee, Y. C. Gary and Rahman, Najib M. (2021) Breathlessness predicts survival in patients with malignant pleural effusions: Meta-analysis of individual patient data from five randomized controlled trials. Chest. ISSN 0012-3692

[img] XML Word Processing Document (DOCX) (Dyspnoea predicts survival in patients with MPEs 280121 clean) - Accepted Version
Restricted to Repository staff only until 1 July 2023.

Download (99kB) | Request a copy
[img] PDF (Accepted_Manuscript) - Accepted Version
Restricted to Repository staff only until 2 March 2022.

Download (281kB) | Request a copy

Abstract

Background: Patients with malignant pleural effusions (MPEs) experience breathlessness and poor survival. Breathlessness is associated with poor survival in other conditions. Research question: Is breathlessness, measured using a visual analogue scale for dyspnoea (VASD), associated with survival in patients with MPE? Study design and methods: Individual patient data from five randomized controlled trials of 553 patients undergoing interventions for MPE were analysed. VASD was recorded at baseline and daily post-intervention. Patients were followed up until death or end of trial. Univariate and multivariable Cox-regression were used to identify factors associated with survival. Results: Baseline VASD was significantly associated with worse survival, with a hazard ratio of 1.10 (95% CI 1.06-1.15) for a 10mm increase in VASD. On multivariable regression, it remained a significant predictor of survival. Mean 7 day VASD and mean total VASD were also predictors of survival (mean 7 day VASD, HR 1.26 (95% CI 1.19-1.34), total VASD, HR 1.25 (95% CI 1.15-1.37)). Other predictors of survival were serum C reactive protein level and tumour type. Previous treatment with chemotherapy, performance status, pleural fluid lactate dehydrogenase, serum albumin, haemoglobin, serum neutrophil:lymphocyte ratio and size of effusion were associated with survival on univariate but not multivariable analysis. Interpretation: Breathlessness, measured using VASD at baseline and post-procedure, is a predictor of survival in patients with MPE.

Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: LivePure Connector
Date Deposited: 13 Mar 2021 00:47
Last Modified: 06 Apr 2021 02:11
URI: https://ueaeprints.uea.ac.uk/id/eprint/79459
DOI: 10.1016/j.chest.2021.02.052

Actions (login required)

View Item View Item